Nexalin 10-Q: Going Concern, Nasdaq Delisting, and PONM Acquisition Terms
NXL sits 17% above its 52-week low of $0.305 on light trading volume (0.1× avg).
Summary
Nexalin Technology's 10-Q reveals a going concern warning, a Nasdaq delisting proceeding, and details of its $1.3M PONM acquisition, all while cash dwindles to $1.0M.
Key Events · Earnings and Guidance · NXL
-
Going Concern Warning
Management concluded the company lacks sufficient cash to fund operations for at least twelve months from the issuance date, with only $1.0M in cash and a $4.3M net loss for H1 2026.
-
Nasdaq Delisting Proceeding
Received Staff Delisting Determination on July 24, 2026 after failing to regain $1.00 minimum bid price compliance; hearing requested; Board approved a 30-to-1 reverse stock split (not yet effective).
-
PONM Acquisition Terms
Acquired PONM for $1.3M in stock: 959,016 shares issued at closing (~$725K fair value), deferred share liability of ~$387K, with down-round protection (floor $0.61, ceiling $1.15) and change-of-control acceleration.
-
ATM Program Dilution
Sold 1,858,344 shares under ATM in H1 2026 for net proceeds ~$895K; $2.654M remains available under the $4.273M program, providing ongoing dilution risk.
Analysis · NXL · Industrial Applications And Services
The Q2 2026 report confirms that Nexalin cannot fund operations for twelve months, has received a Nasdaq delisting determination, and is relying on a 30-to-1 reverse stock split to regain compliance. The PONM acquisition adds $1.3M in stock-based consideration with down-round protection, while the ATM program continues to dilute shareholders. These are existential risks for a micro-cap company with only $1.0M in cash.
At the time of this filing, NXL was trading at $0.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.8M. The 52-week trading range was $0.31 to $2.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.